“The use of testosterone-replacement therapy (TRT) to treat symptoms of ‘male menopause,’ a rapidly growing field of research and an increasingly common clinical concern…” is examined in Canada’s National Review of Medicine. The article suggests that fears of heart or prostate dangers are largely unfounded. Read the article here.
Millions of prescriptions for testosterone have been written these past few years (over 1.8 million in 2002 alone, according to industry estimates), but critics of testosterone replacement therapy have long pointed to an alleged risk of prostate cancer. That concern is unsupported by a small new study which is garnering mainstream media attention.